The New York Times - Business:
Experts say the exploitation of a loophole in the patent system has contributed to high prices for inhalers.
This post first appeared in The New York Times - Business. Read the original article.
Common Patenting Tactic by Drug Companies May Be Illegal, F.T.C. Says
